C4 Therapeutics (CCCC) Leases (2019 - 2025)
Historic Leases for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $42.0 million.
- C4 Therapeutics' Leases fell 2908.04% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 2908.04%. This contributed to the annual value of $57.5 million for FY2024, which is 1003.82% down from last year.
- Latest data reveals that C4 Therapeutics reported Leases of $42.0 million as of Q3 2025, which was down 2908.04% from $54.2 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Leases ranged from a high of $74.8 million in Q1 2022 and a low of $12.2 million during Q3 2021
- Its 5-year average for Leases is $53.5 million, with a median of $60.8 million in 2024.
- In the last 5 years, C4 Therapeutics' Leases surged by 48468.45% in 2022 and then tumbled by 2908.04% in 2025.
- Over the past 5 years, C4 Therapeutics' Leases (Quarter) stood at $31.9 million in 2021, then skyrocketed by 119.49% to $70.1 million in 2022, then fell by 8.79% to $64.0 million in 2023, then decreased by 10.04% to $57.5 million in 2024, then dropped by 27.07% to $42.0 million in 2025.
- Its Leases was $42.0 million in Q3 2025, compared to $54.2 million in Q2 2025 and $55.9 million in Q1 2025.